- decreased circulating glucose level / IMPC
- abnormal coat appearance / IMPC
- decreased locomotor activity / IMPC
- preweaning lethality, complete penetrance / IMPC
- increased mean corpuscular volume / IMPC
- decreased vertical activity / IMPC
- increased urine microalbumin level / IMPC
- embryonic lethality prior to organogenesis / IMPC
STOCK Vezttm1.1Smc/Vezttm1.2Smc/Orl
Status | Available to order |
EMMA ID | EM:04326 |
International strain name | STOCK Vezttm1.1Smc/Vezttm1.2Smc/Orl |
Alternative name | Vezatin flox5/null (or bi-loxP/null vezt strain) |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Vezttm1.1Smc, Vezttm1.2Smc |
Gene/Transgene symbol | Vezt, Vezt |
Information from provider
Provider | Marie-Christine SIMMLER |
Provider affiliation | Neurobiology and development, CNRS |
Genetic information | Vezatin is a integral membrane protein associated to E-cadherin adherens junctions. Exon 5 encodes the transmembranous domain. A conditional vezatin allele lacking exon 5 was generated by using a cre/loxP strategy (original vezt floxed line, EM:01817). This is an heterozygous line modified as follows: one chromosome is carrying an exon-5-only-floxed (Vezt flox5) vezatin allele, i.e. deleted of the floxed pPgk-1-neo-pA cassette (by partial cre recombinase activity) and one chromosome is carrying a null (defloxed) vezatin allele (after deletion of the exon5+neo floxed segment using the pgk1-cre). |
Phenotypic information | Ubiquitous targeted disruption of vezatin results in embryonic lethality due to a failure of epithelialization of the trophectoderm (Hyenne et al., 2007). Hairs cells targeted disruption results in noise-induced hearing loss (Balhoul et al., 2009). |
Breeding history | More than N10 breeding on a mixed/randomized 129/SvPas x B6N. Breeding procedures of heterozygous Vezt Flox5/null x Vezt Flox5/null will only produce Vezt Flox5/null (66%) and Vezt Flox5/Flox5 (33%) mice, since Vezt null/null is an embryonic lethal condition. |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Animals used for archiving | heterozygous 129/Sv x C57BL/6N, heterozygous 129/Sv x C57BL/6N |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
Literature references
- Conditional knock-out reveals that zygotic vezatin-null mouse embryos die at implantation.;Hyenne Vincent, Souilhol Céline, Cohen-Tannoudji Michel, Cereghini Silvia, Petit Christine, Langa Francina, Maro Bernard, Simmler Marie-Christine, ;2007;Mechanisms of development;124;449-62; 17452094
- Vezatin, an integral membrane protein of adherens junctions, is required for the sound resilience of cochlear hair cells.;Bahloul Amel, Simmler Marie-Christine, Michel Vincent, Leibovici Michel, Perfettini Isabelle, Roux Isabelle, Weil Dominique, Nouaille Sylvie, Zuo Jian, Zadro Cristina, Licastro Danilo, Gasparini Paolo, Avan Paul, Hardelin Jean-Pierre, Petit Christine, ;2009;EMBO molecular medicine;1;125-38; 20049712
- Vezatin is essential for dendritic spine morphogenesis and functional synaptic maturation.;Danglot Lydia, Freret Thomas, Le Roux Nicolas, Narboux Nême Nicolas, Burgo Andrea, Hyenne Vincent, Roumier Anne, Contremoulins Vincent, Dauphin François, Bizot Jean-Charles, Vodjdani Guilan, Gaspar Patricia, Boulouard Michel, Poncer Jean-Christophe, Galli Thierry, Simmler Marie-Christine, ;2012;The Journal of neuroscience : the official journal of the Society for Neuroscience;32;9007-22; 22745500
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).